EXOZYMES INC.（EXOZ）内部人交易：高管与董事近期交易
过去 18 个月，共有 5 位内部人为 EXOZYMES INC.（EXOZ）报告了 19 笔 Form 4 交易（最近一笔 2026-09-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-02 | Heltzen Michael | Chief Executive Officer | 买入 | 251 | $1,845 |
| 2026-09-02 | Heltzen Michael | Chief Executive Officer | 买入 | 250 | $1,900 |
| 2026-09-02 | Heltzen Michael | Chief Executive Officer | 买入 | 250 | $1,880 |
| 2026-09-02 | Heltzen Michael | Chief Executive Officer | 买入 | 100 | $750 |
| 2026-09-02 | Heltzen Michael | Chief Executive Officer | 买入 | 8,841 | $56,582 |
| 2026-09-02 | Heltzen Michael | Chief Executive Officer | 买入 | 4 | $30 |
| 2026-08-25 | Korman Tyler Paz | Chief Scientific Officer | 买入 | 32,964 | $0 |
| 2026-08-25 | Perriman Damien Alan | Chief Commercial Officer | 买入 | 19,612 | $0 |
| 2026-04-10 | Korman Tyler Paz | Chief Scientific Officer | 卖出 | 750 | $7,530 |
| 2026-04-10 | Korman Tyler Paz | Chief Scientific Officer | 卖出 | 750 | $7,897 |
| 2026-04-08 | Opgenorth Paul Hideo | Vice President, Development | 买入 | 3,999 | $33,752 |
| 2026-04-08 | Nawaz Fouad | Vice President- Finance | 买入 | 5,999 | $50,632 |
| 2026-04-08 | Korman Tyler Paz | Chief Scientific Officer | 买入 | 5,332 | $45,002 |
| 2026-04-08 | Perriman Damien Alan | Chief Commercial Officer | 买入 | 8,887 | $75,006 |
| 2026-04-08 | Perriman Damien Alan | Chief Commercial Officer | 买入 | 62,759 | $0 |
| 2025-07-02 | Heltzen Michael | Chief Executive Officer | 买入 | 1,040 | $10,629 |
| 2025-06-17 | Opgenorth Paul Hideo | Vice President, Development | 买入 | 2,990 | $37,495 |
| 2025-06-17 | Nawaz Fouad | Vice President, Finance | 买入 | 3,489 | $43,752 |
| 2025-06-17 | Korman Tyler Paz | Vice President, Research | 买入 | 2,990 | $37,495 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02